Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...

LIC has cut its stake in Hindustan Copper by 2% through open-market sales between August and December, reducing its holding to about 4.1%.

Cipla's global CEO Umang Vohra will step down in March 2026. Achin Gupta, currently global COO, will take over as the new MD and GCEO from ...

Cipla Ltd reported a record second-quarter revenue exceeding Rs 7,500 crore, driven by strong demand for its respiratory drugs and a growin...

Cipla shares: Following the earnings announcement, several brokerage firms revised their target price for the stock, with some estimates re...

Cipla Q1 Results: Cipla reported a 10% YoY increase in consolidated net profit, reaching Rs 1,298 crore for the June quarter, driven by a 4...

Shriram Finance Q1 Results: The profit after tax (PAT) increased slightly by 0.8% quarter-on-quarter compared to ₹2,139 crore in Q4FY25, wh...

Markets faced pressure on the weekly expiry day, reversing previous gains. Several companies reported their Q1 results, with IEX, SBI Life,...

Indian markets are expected to focus on companies like HAL and Eicher Motors. These companies will announce their Q4 results. Tata Motors r...

Cipla Q4 Results: The company’s revenue from operations grew by 8.45% year-on-year to Rs 6,597.72 crore, compared to Rs 6,082.37 crore in t...

Anil-Agarwal-led Vedanta has said it is exploring critical mineral assets in states like Maharashtra, Rajasthan, Bihar, Arunachal Pradesh, ...

Sun Pharma is expected to post a 9% year-on-year revenue growth, supported by its US specialty portfolio and steady growth in chronic thera...

Cipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth. Brokerages have differi...

Stocks in news: Waaree Renewable Technologies has secured an order worth Rs 277.20 crore for setting up a ground-mounted solar project of 1...

Meanwhile, EBITDA for the quarter under review increased 13% YoY to Rs 1,316 crore as against 1166 crore in the last year period.

The aggregate earnings of the companies in the MOFSL universe exceeded expectations and rose 29% year-on-year (YoY) versus an estimated 19%...

Cipla, incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 77566.07 Crore) operating in Pharmaceuticals sector.